DuPont China is suspected of violating the Anti-Monopoly Law and has been officially investigated by the State Administration for Market Regulation (SAMR). What are the specifics?

On the evening of April 4, 2025, the State Administration for Market Regulation (SAMR) announced that DuPont China Group Co., Ltd. was under formal investigation for suspected violations of the People’s Republic of China Anti-Monopoly Law (SAMR official website, April 4, 2025). That same day, DuPont’s U.S.-listed shares plunged over 9% in pre-market trading (Yicai News, April 4, 2025). On July 22, 2025, SAMR issued another notice: the anti-monopoly investigation into DuPont China Group Co., Ltd. was suspended (SAMR official website, July 22, 2025). Note: it says ‘suspended’, not ‘concluded’—the official announcement consists of just one sentence, disclosing neither the reason for suspension nor whether or when the investigation might resume. In other words, as of last July, the matter stood officially suspended. Online rumors—such as claims that the probe targeted DuPont’s dominant market position in aramid fibers (Kevlar/Nomex) or that DuPont submitted a rectification plan—are largely media paraphrases; the official announcements contain no details on the specific grounds for investigation. Without official confirmation, I cannot verify or refute such reports, and thus refrain from elaborating further here. So what is DuPont’s real new development today (August 4)? It released its Q2 2026 financial results—and its U.S.-listed shares fell 7.6% in pre-market trading (Caixin Media, August 4). The flash news attributed the drop to the company’s ‘downward revision of its full-year sales forecast’. However, upon reviewing DuPont’s official earnings press release issued the same day, the headline reads: ‘Raises Full Year 2026 Guidance’—i.e., an upward revision of its full-year outlook. The two accounts contradict each other. Which is accurate? Let’s compare the official figures (source: DuPont Q2 2026 Earnings Release, published August 4, 2026): ・Full-year net sales guidance: $7.16–$7.19 billion. Compared with the prior range of $7.155–$7.215 billion following the Q1 earnings in May, the interval has narrowed slightly, and the midpoint declined marginally—from $7.185 billion to $7.175 billion (a $0.1 billion decrease); ・Full-year operating EBITDA guidance: $1.75–$1.77 billion, up from the previous $1.73–$1.76 billion; ・Full-year adjusted EPS guidance: $7.17–$7.32, clearly higher than the prior $7.02–$7.16. Strictly speaking, the claim that DuPont ‘lowered its full-year sales forecast’ does not align with the official release—both profit-related guidance metrics were raised, while only the net sales range was narrowed slightly, with its midpoint down by $0.1 billion. The flash news likely mischaracterized this ‘narrowing of the range’ as a ‘downward revision’, or referred to something else entirely—but I found no official statement from DuPont indicating a ‘downward revision of annual sales expectations’. Therefore, we must rely solely on the official figures. As for the 7.6% pre-market decline itself—the price movement is factual (confirmed consistently by Caixin Media, Glonass, and other news outlets). Yet on that same day, U.S. equity markets rose overall (Dow futures up over 1%; Caterpillar up over 11% pre-market). Attributing DuPont’s drop solely to a ‘revised-down sales forecast’ finds no support in the official materials.

Raw material prices rose by 40%, yet DuPont raised its full-year guidance—what gives specialty plastics the pricing power to hike prices?

Q1 2026 revenue totaled $1.68 billion, up 4.3% year-on-year. On May 5, DuPont (NYSE: DD) reported first-quarter results that surprised the market positively—especially against the backdrop of broad-based cost increases across the global chemical industry. Source: DuPont At the same time, DuPont updated its full-year and Q2 2026 financial guidance—overall expectations proved stronger than the market had previously anticipated. Specifically, Q2 net sales are expected to reach approximately $1.8 billion, operating EBITDA around $430 million, and adjusted EPS about $0.59; full-year net sales are projected between $7.155 billion and $7.2155 billion, with adjusted EPS forecast at $2.35–$2.40—both above prior market consensus estimates of $7.1 billion in revenue and $2.27 in EPS. Yet the truly meaningful takeaway from this report lies not in these beat-the-street numbers—but in the logic they conceal: amid surging raw material costs, why did DuPont—a specialty materials company—deliver strong Q1 results and dare raise its full-year guidance? The answer to this question also serves as a key to understanding today’s global materials market structure. At CHINAPLAS 2026—the International Plastics & Rubber Show held recently in Shanghai—many exhibitors showcased products offering their own answers. The Pricing Logic Behind the Price Hikes First, let’s clarify the context behind the earnings report. Since late February 2026, escalating Middle East conflict has significantly disrupted oil and petrochemical logistics near the Strait of Hormuz, straining the global chemical supply chain. Data show polyethylene (PE) and polypropylene (PP) prices have risen 32.6% and 41.5%, respectively, since the outbreak of hostilities—figures that reflect not isolated commodity fluctuations but systemic tremors across the entire materials cost structure. Faced with this situation, DuPont adopted a direct response: passing on roughly $90 million in incremental costs to downstream customers via surcharges and price adjustments—and expects full coverage starting in Q2. CFO Antonella Franzen explicitly stated on the earnings call that approximately 1% of the company’s full-year organic growth will stem from pricing actions, fully offsetting rising input costs. Notably, this is not ordinary ‘demand-driven inflation’, but rather a deeper risk-cost pass-through mechanism—when the entire cost system faces uncertainty, large-scale materials suppliers reallocate risk through contractual terms, and the direction of that reallocation flows downstream. What does this mean for downstream procurement? In future material quotations, temporary surcharges—including energy surcharges, logistics surcharges, and raw-material volatility adjustments—will become increasingly common. The traditional procurement model—based on quarterly or annual fixed-price contracts—is giving way to more flexible, dynamic pricing mechanisms. This trend is especially pronounced in the specialty materials sector. Specialty Plastics: Structural Advantages Amid Cost Shocks Not all materials companies possess such pricing confidence. DuPont’s ability to do so rests on a critical premise: it sells specialty—not commodity—materials. From DuPont’s Q1 business breakdown: the Healthcare & Water Technologies segment posted net sales growth of 5.6% to $806 million, strongly supported by medical packaging and biopharmaceutical markets; the Multi-Industrial segment saw sales rise 3% to $875 million, driven by robust aerospace and automotive demand.

DuPont (DD) Earnings Report Expected Tomorrow

May 4, 2026

DuPont (DD) is scheduled to release earnings tomorrow with a consensus estimate of 48 cents per share. Investors should weigh the GF Score of 71 against mixed financials and over $6.3 million in recent insider selling.

GuruFocus

2026-04-21

UBS Raises Corteva Price Target to $88, Maintains Neutral Rating

2026-04-22

DuPont de Nemours Inc. Stock Underperforms vs Competitors on Wednesday

2026-04-24

DuPont’s Electronics Spinoff Qnity Prices $4.1B Debt Deal Ahead of November Split

2026-04-24

RBC Adjusts Price Target on DuPont de Nemours to $56 From $60, Maintains Outperform Rating

2026-04-28

Morgan Stanley Adjusts DuPont de Nemours Price Target to $52 From $44, Maintains Equal Weight Rating